Physician profile
Antoine Ibrahim Jabbour
NPI 1588632905
$55,164.59
in general payments reported to CMS, 2019-2025
18 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,927 · 2020: $1,566 · 2021: $2,949 · 2022: $1,608 · 2023: $38K · 2024: $358 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Food and Beverage: $1,427 · Travel and Lodging: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,200.00 |
| Food and Beverage | $1,426.81 |
| Travel and Lodging | $487.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $37,260.06 | 2019-2023 | |
| Pacira Therapeutics, INC. | $12,484.87 | 2019-2021 | |
| Pylant Medical | $2,859.03 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $737.68 | 2021-2025 | Iovera, Zilretta, Exparel |
| Sanofi-Aventis U.S. LLC | $656.58 | 2019-2023 | |
| Davol INC. | $215.87 | 2024 | Arista Ah Flexitip |
| Stryker Corporation | $187.28 | 2022-2025 | Gamma, Mako |
| Bioventus LLC | $180.97 | 2019-2024 | Durolane |
| Smith+Nephew, INC. | $160.64 | 2019-2025 | Collagenase Santyl |
| Depuy Synthes Sales INC. | $81.61 | 2019-2025 | Na, Lcp |
| Horizon Therapeutics Plc | $80.88 | 2019-2022 | |
| P Bar Medical LLC | $70.41 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $58.59 | 2025 | |
| Zyla Life Sciences, INC. | $42.64 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $26.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthalign INC | $25.90 | 2023 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $18.11 | 2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Aesculap Biologics, LLC | $16.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antoine Jabbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.